Metabolomic Assay, Computational Screening, and Pharmacological Evaluation of as an Anti-obesity With Anti-aging by Altering Lipid Profile and Peroxisome Proliferator-Activated Receptor-γ Coactivator 1-α Levels.

Happy Kurnia Permatasari, Fahrul Nurkolis, Hardinsyah Hardinsyah, Nurpudji Astuti Taslim, Nindy Sabrina, Faisal Maulana Ibrahim, Jodi Visnu, Dian Aruni Kumalawati, Sri Awalia Febriana, Toto Sudargo, Melvin Junior Tanner, Isma Kurniatanty, Vincentius Mario Yusuf, Ronald Rompies, Muhammad Rahimi Bahar, Holipah Holipah, Nelly Mayulu
Author Information
  1. Happy Kurnia Permatasari: Department of Biochemistry and Biomolecular, Faculty of Medicine, Brawijaya University, Malang, Indonesia.
  2. Fahrul Nurkolis: Department of Biological Sciences, Sunan Kalijaga State Islamic University, Yogyakarta, Indonesia.
  3. Hardinsyah Hardinsyah: Department of Applied Nutrition, IPB University, Bogor, Indonesia.
  4. Nurpudji Astuti Taslim: Department of Clinical Nutrition, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.
  5. Nindy Sabrina: Department of Nutrition, Dietetics and Food, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
  6. Faisal Maulana Ibrahim: Pharmaceutical Analysis and Medicinal Chemistry, Universitas Padjadjaran, Sumedang, Indonesia.
  7. Jodi Visnu: Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
  8. Dian Aruni Kumalawati: Department of Biological Sciences, Sunan Kalijaga State Islamic University, Yogyakarta, Indonesia.
  9. Sri Awalia Febriana: Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
  10. Toto Sudargo: Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
  11. Melvin Junior Tanner: Department of Nutrition, Faculty of Public Health, University of Indonesia, Depok, Indonesia.
  12. Isma Kurniatanty: Department of Biological Sciences, Sunan Kalijaga State Islamic University, Yogyakarta, Indonesia.
  13. Vincentius Mario Yusuf: Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
  14. Ronald Rompies: Faculty of Medicine, Sam Ratulangi University, Manado, Indonesia.
  15. Muhammad Rahimi Bahar: Faculty of Medicine, Sam Ratulangi University, Manado, Indonesia.
  16. Holipah Holipah: Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
  17. Nelly Mayulu: Faculty of Medicine, Sam Ratulangi University, Manado, Indonesia.

Abstract

Obesity is associated with an accelerated aging process, which prevents healthy aging. Both obesity and aging were manifested in the peroxisome proliferator-activated receptor-γ coactivator α (PGC-1α) level. These studies fulfill the scientific gap in assembled pharmacological activity assay of done in a previous preclinical trial. Six major compounds from sea grape () extract were evaluated using an approach against human pancreatic , , and to predict prospective anti-obesity candidates. The inhibitory activity of the extract reached 90.30 ± 0.40%, 1.75% lower than orlistat. The inhibitory assay of the extract was 84.07 ± 5.28%, while the inhibitory activity against was 81.67 ± 1.54%; both were lower than acarbose. We observe the effect of extract as anti-obesity with anti-aging by evaluating the obesity parameters in the human body for a 4-week period. There was a significant decrease in blood glucose, total cholesterol, low-density lipoprotein (LDL), triglycerides (TG), waist circumference, waist-hip ratio, and body weight ( < 0.05); PGC-1α and high-density lipoprotein (HDL) increased significantly ( = 0.000), in Group B when compared with Group A. Our study revealed that sea grape extract is a potent anti-obesity with an anti-aging reagent that does not produce any significant adverse effects.

Keywords

References

  1. J Food Sci Technol. 2018 Jun;55(6):2310-2317 [PMID: 29892131]
  2. Diabetes Metab Syndr Obes. 2020 Oct 28;13:4041-4049 [PMID: 33149643]
  3. Biol Rev Camb Philos Soc. 2016 May;91(2):452-68 [PMID: 25740151]
  4. Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1467-74 [PMID: 27312223]
  5. Biomed Pharmacother. 2020 Aug;128:110314 [PMID: 32485574]
  6. Ageing Res Rev. 2018 Jul;44:8-21 [PMID: 29580918]
  7. Arch Dis Child. 2006 Feb;91(2):121-5 [PMID: 16174642]
  8. Int J Mol Sci. 2018 Nov 02;19(11): [PMID: 30400212]
  9. Phytother Res. 2013 Mar;27(3):374-9 [PMID: 22610853]
  10. Menopause. 2012 Jul;19(7):760-7 [PMID: 22395454]
  11. Biomed Pharmacother. 2019 Feb;110:582-593 [PMID: 30537675]
  12. Int J Oncol. 2017 Jan;50(1):161-172 [PMID: 27922662]
  13. Psychiatry Res. 1989 May;28(2):193-213 [PMID: 2748771]
  14. Antibiotics (Basel). 2019 Sep 17;8(3): [PMID: 31533237]
  15. Am J Hypertens. 1988 Jul;1(3 Pt 1):309-12 [PMID: 3291897]
  16. PLoS One. 2013 Apr 25;8(4):e62546 [PMID: 23638112]
  17. Adv Physiol Educ. 2006 Dec;30(4):145-51 [PMID: 17108241]
  18. Mar Drugs. 2009 Nov 26;7(4):689-704 [PMID: 20098607]
  19. Phytother Res. 2021 Aug;35(8):4377-4387 [PMID: 33893671]
  20. Lancet Public Health. 2018 Oct;3(10):e490-e497 [PMID: 30177479]
  21. Mol Biol Rep. 2020 Oct;47(10):7403-7411 [PMID: 32990904]
  22. Bioorg Med Chem. 2015 Jan 1;23(1):38-45 [PMID: 25497963]
  23. Obes Rev. 2007 May;8(3):191-6 [PMID: 17444961]
  24. J Carcinog. 2021 May 06;20:4 [PMID: 34321955]
  25. Recent Pat Anticancer Drug Discov. 2012 May 1;7(2):154-67 [PMID: 22339355]
  26. Prostaglandins Other Lipid Mediat. 2016 Sep;125:8-18 [PMID: 27418542]
  27. Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1038-51 [PMID: 26962700]
  28. Res Pharm Sci. 2020 Aug 28;15(4):401-409 [PMID: 33312218]
  29. F1000Res. 2021 Aug 2;10:718 [PMID: 35136575]
  30. Endocr Rev. 2003 Feb;24(1):78-90 [PMID: 12588810]
  31. Dis Model Mech. 2012 May;5(3):293-5 [PMID: 22566556]
  32. Biomed Res Int. 2015;2015:217047 [PMID: 26539470]
  33. Mini Rev Med Chem. 2019;19(9):751-761 [PMID: 28971770]
  34. F1000Res. 2021 Aug 11;10:789 [PMID: 36237995]
  35. Pediatrics. 2004 May;113(5):1187-94 [PMID: 15121928]
  36. Metabolites. 2020 Dec 07;10(12): [PMID: 33297424]
  37. Stem Cells Int. 2016;2016:6067349 [PMID: 27073398]
  38. Nutr Diabetes. 2019 Aug 27;9(1):23 [PMID: 31455758]
  39. Foods. 2020 Sep 18;9(9): [PMID: 32961907]
  40. Pharmacoeconomics. 2015 Jul;33(7):673-89 [PMID: 25471927]
  41. Skelet Muscle. 2020 May 6;10(1):14 [PMID: 32375875]
  42. Hum Reprod Update. 2017 May 1;23(3):300-321 [PMID: 28333235]

Word Cloud

Created with Highcharts 10.0.0extractagingobesityPGC-1αactivityanti-obesityinhibitory±0assayseagrapehuman1loweranti-agingbodysignificantlipoproteinGroupObesityassociatedacceleratedprocesspreventshealthymanifestedperoxisomeproliferator-activatedreceptor-γcoactivatorαlevelstudiesfulfillscientificgapassembledpharmacologicaldonepreviouspreclinicaltrialSixmajorcompoundsevaluatedusingapproachpancreaticpredictprospectivecandidatesreached903040%75%orlistat8407528%816754%acarboseobserveeffectevaluatingparameters4-weekperioddecreasebloodglucosetotalcholesterollow-densityLDLtriglyceridesTGwaistcircumferencewaist-hipratioweight<05high-densityHDLincreasedsignificantly=000BcomparedstudyrevealedpotentreagentproduceadverseeffectsMetabolomicAssayComputationalScreeningPharmacologicalEvaluationAnti-obesityAnti-agingAlteringLipidProfilePeroxisomeProliferator-ActivatedReceptor-γCoactivator1-αLevelsCaulerparacemosalipidprofilenutraceuticals

Similar Articles

Cited By